4.6 Review

Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes

期刊

AAPS JOURNAL
卷 17, 期 4, 页码 788-801

出版社

SPRINGER
DOI: 10.1208/s12248-015-9752-6

关键词

membrane transporters; molecular imaging; multidrug resistance; near infrared; optical imaging

资金

  1. Israeli Cancer Research Foundation (ICRF)
  2. Israel Science Foundation (ISF) [506/13]

向作者/读者索取更多资源

Molecular imaging allows the non-invasive assessment of membrane transporter expression and function in living subjects. Such technologies have the potential to become diagnostic and prognostic tools, allowing detection, localization, and prediction of response of tumors and their metastases to therapy. Beyond tumors, imaging can also help understand the role of transporters in adverse drug effects and drug clearance. Here, we review molecular imaging technologies that monitor transporter-mediated processes. We emphasize emerging probe substrates and potential clinical applications of imaging the function of membrane transporters in cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Antiseizure medications and fetal nutrients: Effects on choline transporters in a human placental cell line

Nino Tetro, Sonia Moushaev, Miri Shmuel, Sara Eyal

Summary: The study found that antiseizure medications, especially at high therapeutic concentrations, may interfere with the placental uptake of choline. Therefore, careful adjustment of maternal doses of ASM is needed during pregnancy.

EPILEPSIA (2021)

Editorial Material Clinical Neurology

Guardians of the Frequency: Neuronal Regulation by Microglia

Sara Eyal

EPILEPSY CURRENTS (2021)

Review Environmental Sciences

Plant pharmacology: Insights into in-planta kinetic and dynamic processes of xenobiotics

Tomer Malchi, Sara Eyal, Henryk Czosnek, Moshe Shenker, Benny Chefetz

Summary: This paper introduces a novel approach to understand the interactions between bioactive pollutants and plants through the concept of plant pharmacology, dividing it into plant pharmacokinetics and plant pharmacodynamics, which discuss the fate of exogenous xenobiotics in plants and their impact on plant enzymes and biochemical pathways.

CRITICAL REVIEWS IN ENVIRONMENTAL SCIENCE AND TECHNOLOGY (2022)

Review Clinical Neurology

Not your usual drug-drug interactions: Monoclonal antibody-based therapeutics may interact with antiseizure medications

Erez Berman, Iris Noyman, Mordekhay Medvedovsky, Dana Ekstein, Sara Eyal

Summary: Therapeutic monoclonal antibodies (mAbs) are increasingly being co-prescribed with other drugs, such as antiseizure medications (ASMs), raising concerns about potential drug interactions and treatment outcome. This literature review identified key issues related to mAb-ASM combinations and provided practice recommendations for clinicians. Further research is needed to establish class-based recommendations for mAb-ASM interactions to ensure safe and effective treatment for patients with epilepsy.

EPILEPSIA (2022)

Editorial Material Clinical Neurology

Exploring the Cognitive Outcomes of Children Prenatally Exposed to Antiseizure Medications: Mind the Lab

Sara Eyal

Summary: This study compared cognitive abilities of 2-year-old children born to women with epilepsy (WWE) versus healthy women, and found that maximum ASM exposure in the third trimester of WWE was associated with cognitive and motor abilities in children.

EPILEPSY CURRENTS (2022)

Article Pharmacology & Pharmacy

PEGylated Liposomes Remotely Loaded with the Combination of Doxorubicin, Quinine, and Indocyanine Green Enable Successful Treatment of Multidrug-Resistant Tumors

Emma Grabarnick (Portnoy), Alexander V. Andriyanov, Hadas Han, Sara Eyal, Yechezkel Barenholz

Summary: The study demonstrated that the combined treatment of liposomal doxorubicin, P-gp inhibitor quinine, and photodynamic therapy with indocyanine green can overcome multidrug resistance in cancer cells, particularly showing significant therapeutic effects in an adenocarcinoma drug-resistant tumor model.

PHARMACEUTICS (2021)

Editorial Material Clinical Neurology

Using nirmatrelvir/ritonavir in patients with epilepsy: An update from the Israeli chapter of the International League Against Epilepsy

Iris Noyman, Dana Ekstein, Firas Fahoum, Moshe Herskovitz, Ilan Linder, Bruria Ben Zeev, Sara Eyal

Summary: The recommendations suggest caution in using nirmatrelvir/ritonavir in patients with epilepsy who are on moderate-to-strong enzyme-inducing antiseizure medications (ASMs) and everolimus. It is advised to consider rectal diazepam as an alternative to buccal midazolam, adjust doses of ASMs that are cytochrome P450 (CYP3A4) substrates, and monitor drug efficacy and adverse drug reactions in patients treated with combinations of nirmatrelvir/ritonavir and ASMs that are CYP3A4 substrates or lamotrigine.

EPILEPSIA (2022)

Article Clinical Neurology

Lacosamide effects on placental carriers of essential compounds in comparison with valproate: Studies in perfused human placentas

Erez Berman, Elkana Kohn, Matitiahu Berkovitch, Michal Kovo, Sara Eyal

Summary: This study found that lacosamide at high therapeutic concentrations exerted pharmacological effects on the human placenta, potentially affecting folate supply to the fetus. These findings suggest the importance of therapeutic monitoring and careful adjustment of lacosamide plasma concentrations during pregnancy.

EPILEPSIA (2022)

Editorial Material Clinical Neurology

Should We Be Going With Our Patient's Gut (Bacteria)? The Intestinal Microbiota and Epilepsy Treatments

Sara Eyal

Summary: In an observational study of 28 children with drug-resistant epilepsy treated with the ketogenic diet, changes in gut microbiota and inflammation were identified during treatment. The findings suggest a general anti-inflammatory effect of KD, and specific Bifidobacteria and TNF may be associated with the efficacy of KD.

EPILEPSY CURRENTS (2022)

Editorial Material Clinical Neurology

In silico screening for clinical efficacy of antiseizure medications: Not all central nervous system drugs are alike

Roaa Hamed, Amit David Eyal, Erez Berman, Sara Eyal

EPILEPSIA (2023)

Review Clinical Neurology

Intracerebroventricular administration for delivery of antiseizure therapeutics: Challenges and opportunities

Firas Fahoum, Sara Eyal

Summary: Intracerebroventricular (ICV) administration is explored as a means to deliver antiseizure and antiepileptic therapies to epileptic brain tissue. This route bypasses the blood-brain barrier, allowing restricted therapeutics to reach the brain while reducing systemic adverse reactions. However, efficacy may be limited when epileptogenic tissue is far from the ventricles. This article provides an overview of ICV delivery and its challenges, and compares it with other administration routes.

EPILEPSIA (2023)

Editorial Material Clinical Neurology

An Electric Light Orchestra in the Brain: Optogenetics for Controlling Seizures via Modulation of Astrocyte Activity

Sara Eyal

Summary: In this study, the researchers found that activating channelrhodopsin-2-expressing astrocytes effectively reduces neocortical seizures in rodent models. This anti-seizure effect is independent of classical calcium signaling and is instead related to the astrocytic Na+K+-ATPase-mediated buffering K+, which inhibits firing in highly active pyramidal neurons during seizures. Compared to inhibiting pyramidal neurons, stimulating astrocytes has several advantages as an anti-seizure strategy, including a wider therapeutic window, greater efficacy, and minimal side effects. Furthermore, optogenetic-driven astrocytic Na+K+-ATPase shows promising therapeutic effects in a chronic focal cortical dysplasia epilepsy model.

EPILEPSY CURRENTS (2023)

Article Clinical Neurology

Placental disposition of cannabidiol: An ex vivo perfusion study

Erez Berman, Natalia Erenburg, Ron Beloosesky, Sara Eyal, Michal Kovo

Summary: The study found that CBD is sequestered in placental tissue, with lower concentrations in the fetal compartment. CBD did not significantly alter placental gene expression. While the placenta acts as a depot for CBD, there are still potential risks associated with its use during pregnancy.

EPILEPSIA (2023)

Article Clinical Neurology

First unprovoked seizures among soldiers recruited to the Israeli Defense Forces during 10 consecutive years: A population-based study

Adili Tsur, Ronen Spierer, Renana Cohen, Dana Blatch, Sara Eyal, Asaf Honig, Dana Ekstein

Summary: The incidence rate of first unprovoked seizures (FUS) is higher in combat soldiers, but they have a two-fold lower risk of additional seizures compared to noncombat soldiers. This highlights the value of strenuous triggers as negative predictors for developing epilepsy and suggests a shift in the perception of epilepsy, calling for changes in the weighting of epilepsy etiologies and delivery of treatments.

EPILEPSIA (2023)

Editorial Material Clinical Neurology

A Postictal Traffic Jam

Sara Eyal

Summary: Cerebral hypoperfusion, which is characterized by decreased cerebral blood flow (CBF), is proposed as a potential cause of postictal neurological dysfunction in epilepsy. The study shows that a 30% reduction in postictal CBF has two contributing factors. The early hypoperfusion is mainly induced by arteriolar constriction, while the prolonged hypoperfusion is due to neutrophil adhesion to brain capillaries, decreased red blood cell flow, capillary and venule constriction, and elevated ICAM-1 expression. Antibodies against neutrophil marker Ly6G and against LFA-1 can prevent neutrophil adhesion and recover CBF reductions to control levels.

EPILEPSY CURRENTS (2023)

暂无数据